Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

KERN, FRED

NPI: 1447245006 · BRIDGEWATER, MA 02324 · Pediatrics Physician · NPI assigned 09/20/2005

$1.33M
Total Medicaid Paid
32,727
Total Claims
30,422
Beneficiaries
38
Codes Billed
2018-01
First Month
2023-03
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,386 $287K
2019 7,756 $299K
2020 5,358 $223K
2021 6,365 $267K
2022 5,385 $240K
2023 477 $19K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,131 2,867 $296K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,069 4,679 $293K
90460 Immunization administration through 18 years of age via any route, first or only component 5,050 3,715 $156K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1,023 1,022 $85K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,478 1,394 $76K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 895 895 $75K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 538 528 $39K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 409 408 $37K
90461 1,065 1,057 $37K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 3,834 3,822 $35K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 444 443 $35K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,165 1,139 $34K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,242 1,161 $30K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2,048 2,045 $23K
96127 1,847 1,833 $20K
92587 457 454 $16K
99177 438 437 $7K
99173 311 311 $7K
0071A 122 122 $6K
97803 54 39 $5K
0072A 104 104 $5K
83655 304 304 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 121 108 $3K
36416 194 194 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 91 91 $2K
87634 28 27 $2K
94760 710 670 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 41 41 $1K
85018 359 359 $852.16
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 41 41 $744.69
0081A 13 13 $596.44
0001A 12 12 $550.56
0074A 12 12 $550.56
92552 16 16 $260.96
87807 15 15 $164.10
80061 Lipid panel 12 12 $146.52
81002 21 19 $53.97
36415 Collection of venous blood by venipuncture 13 13 $28.86